PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
SEATTLE and RICHMOND, BC , Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. ...
2026-08-26T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide
Expanded agreement combines PENTAX Medical's continued investment in flexible reusable endoscopy with MAGENTIQ's clinically validated AI capabilities, expanding access to AI-assisted colonoscopy across ...
2026-08-26T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Alebund Pharmaceuticals Announces 2026 Interim Results
SHANGHAI , Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today ...
2026-08-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
China's BCI Race Accelerates: Gestala Raises US$84 Million in Six Months
SHANGHAI and CHENGDU, China , Aug. 26, 2026 /PRNewswire/ -- Gestala officially launched on January 1, 2026. Six months later, the company had completed two financing rounds totaling RMB 570 million, ...
2026-08-26T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Caliway's CBL-514 Combination Therapy Cleared by U.S. FDA for Phase 2 Trial; Pivotal Phase 3 Trial SUPREME-01 Initiates Enrollment
FDA IND Clearance for CBL-0201WR —Caliway has cleared its Investigational New Drug application for CBL-0201WR, a Phase 2 trial evaluating CBL-514 in combination with tirzepatide. U.S. IRB Approval ...
2026-08-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell
KEY POINTS ...
2026-08-26T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Completes Landmark Global Health Pilot Advancing Women's and Infant Health
Innovative sample collection methods developed through Gates Foundation-funded grant enable high-quality metabolomics biomarker discovery in populations from low- and middle-income countries ...
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi Biologics Reports Strong Profitable Growth in H1 2026
Revenue of RMB 11.8 billion grew 18.4% YoY (23.4% YoY in USD) IFRS gross profit margin expanded to 46.2% (+350 bps YoY) and adjusted gross profit margin expanded to 48.4% (+280 bps YoY), despite foreign ...
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Fosun Pharma Announces 2026 Interim Results
Globalization Accelerates Value Realization of Innovative Drugs ...
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innovent Announces 2026 Interim Results and Business Updates
Transforming from Regional Leader to Global Premier: ...
2026-08-25T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved